Ministry of Food and Drug Safety: Rebound Continues After Endemic Shock

Implants and Ultrasound Devices Lead Export Growth

Production and exports of medical devices, which had contracted due to a sharp decline in demand for COVID-19 diagnostic kits, have continued to rise for two consecutive years.


Medical Device Production and Exports Rebound for Second Consecutive Year... Trade Surplus Reaches $330 Million View original image

The Ministry of Food and Drug Safety announced on May 28 that, based on an analysis of domestic medical device production, export, and import performance, the medical device trade balance recorded a surplus of 478.9 billion won (330 million USD) last year. This marks six consecutive years of surplus since 2020.


Domestic medical device production and export values reached 12.3558 trillion won and 7.6395 trillion won (5.37 billion USD), respectively, representing year-on-year increases of 8.1% and 2.2%. These increases are larger than the growth rates of 1.0% and 1.4% recorded in 2024.


By product category, exports of in vitro diagnostic medical devices—which had plummeted after the COVID-19-related boom subsided—rebounded, with export value reaching 738 million USD, a 6.0% increase from the previous year. This recovery was driven by increased production and export of PCR-based diagnostic products for non-respiratory diseases, such as gastrointestinal infections and human papillomavirus (HPV), rather than COVID-19.


For traditional market leaders in Korea's medical device sector, the production value of “dental implant fixtures” rose 12.2% year-on-year to 2.4429 trillion won, maintaining the top production spot for the third consecutive year. In exports, “general-purpose ultrasound diagnostic devices” led with a 10.2% year-on-year increase, totaling 529 million USD and ranking first in export value.


Medical Device Production and Exports Rebound for Second Consecutive Year... Trade Surplus Reaches $330 Million View original image

Driven by population aging and heightened interest in skin care, the market for skin improvement-related medical devices also grew rapidly. Production of “general-purpose electrosurgical units,” commonly used for skin wrinkle improvement, surged by 36.9% year-on-year, with exports up 48.9% and imports up 69.4%. Exports of “disposable hand-controlled electrosurgical electrodes,” used in conjunction with these devices, soared by 82.0%. Production, export, and import values for tissue restoration biomaterials—commonly known as “fillers”—also increased by 7.9%, 1.6%, and 25.2%, respectively, compared to the previous year.


The trend toward diversification in medical device export markets was also clear. Last year, Korean medical devices were exported to a total of 203 countries. The combined share of the four major export destinations—United States, China, Japan, and Russia—fell by 2.9 percentage points to 35.9%, while exports to Europe and Asia, including Germany (8.6%), India (10.3%), Thailand (16.3%), and France (12.8%), all rose steadily, successfully reducing dependence on any single country.


As of 2025, the number of domestic medical device manufacturers and importers totaled 7,570, up 2.2% from the previous year, while the number of employees reached 162,531, a 7.8% increase, marking nearly double-digit growth for the second consecutive year.



The Ministry of Food and Drug Safety stated, “We will continue to do our utmost to promote the development of the medical device industry, actively supporting the rapid market entry of newly developed medical devices, strengthening competitiveness through global regulatory leadership and regulatory support, and enabling Korea to advance as a powerhouse in bio-health.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing